BHCC(600800)2024-10-29 08:26Financial Performance - The company's operating revenue for Q3 2024 was ¥871,923,653.14, a decrease of 14.38% compared to the same period last year[2]. - The net profit attributable to shareholders was a loss of ¥221,730,165.11, with a year-to-date loss of ¥537,248,823.86[2]. - The basic and diluted earnings per share were both -¥0.20, reflecting a significant decline[3]. - The weighted average return on equity decreased by 6.67 percentage points to -11.18% for the quarter[3]. - The net loss for the first three quarters of 2024 was CNY 537,248,277.70, compared to a net loss of CNY 394,457,840.20 in the same period of 2023, reflecting a deterioration in financial performance[15]. - The total comprehensive income for the period was -537,430,558.40 RMB, compared to -393,875,431.34 RMB in the same period last year, indicating a decline of approximately 36.4%[17]. - The basic and diluted earnings per share were both -0.48 RMB, compared to -0.33 RMB in the same period last year, indicating a decline of about 45.5%[17]. Assets and Liabilities - Total assets at the end of the reporting period were ¥3,837,732,063.08, down 10.29% from the end of the previous year[3]. - The equity attributable to shareholders decreased by 22.26% to ¥1,859,585,326.40[3]. - The company's total assets decreased from CNY 4,278,152,789.83 at the end of 2023 to CNY 3,837,732,063.08 by the end of Q3 2024[13]. - Total liabilities increased from CNY 1,886,176,863.91 in 2023 to CNY 1,977,166,190.52 in Q3 2024, indicating a rise of approximately 4.8%[13]. - The equity attributable to shareholders decreased from CNY 2,391,975,925.92 in 2023 to CNY 1,859,585,326.40 in Q3 2024, a decline of about 22.2%[13]. - The total non-current liabilities rose from CNY 288,286,001.12 in 2023 to CNY 597,605,167.53 in Q3 2024, indicating an increase of approximately 107.5%[13]. Revenue and Costs - The company reported a significant increase in operating revenue year-to-date, up 37.71% due to increased product sales[6]. - Total operating revenue for the first three quarters of 2024 reached CNY 3,377,035,640.94, a significant increase from CNY 2,452,365,655.77 in the same period of 2023, representing a growth of approximately 37.5%[14]. - Total operating costs for the first three quarters of 2024 were CNY 3,947,487,620.88, up from CNY 2,914,016,485.67 in 2023, indicating an increase of about 35.4%[14]. Cash Flow - The net cash flow from operating activities was -171,850,206.89 RMB, an improvement from -322,226,870.07 RMB year-over-year[18]. - Cash inflows from operating activities totaled 3,996,787,235.37 RMB, up from 3,084,402,900.44 RMB, representing an increase of about 29.6%[18]. - Cash outflows for operating activities increased to 4,168,637,442.26 RMB from 3,406,629,770.51 RMB, reflecting a rise of approximately 22.4%[18]. - The company reported cash inflows from financing activities of 1,480,759,696.59 RMB, compared to 585,413,182.53 RMB in the previous year, marking an increase of about 152.3%[19]. - The net cash flow from financing activities was 137,263,633.74 RMB, a significant recovery from -273,663,423.07 RMB in the same period last year[19]. - The cash and cash equivalents at the end of the period stood at 585,453,228.91 RMB, down from 784,826,263.20 RMB year-over-year, a decrease of approximately 25.4%[19]. Shareholder Information - The total number of common shareholders at the end of the reporting period is 39,448, with the largest shareholder holding 28.41%[8]. - The largest shareholder, Tianjin Bohai Chemical Group, holds 315,392,855 shares, accounting for a significant portion of the company's equity[8]. - The second-largest shareholder, Tianjin Global Magnetic Card Group, holds 105,431,347 shares, representing 9.50% of the total shares[8]. - The company has not reported any significant changes in the participation of major shareholders in margin trading or securities lending activities[9]. Other Financial Metrics - The company received government subsidies amounting to ¥4,000,000.00 during the reporting period[4]. - Non-recurring gains and losses totaled ¥4,263,198.10 for the quarter, with a year-to-date total of ¥9,257,209.51[5]. - Research and development expenses for the first three quarters of 2024 amounted to CNY 128,135,206.26, slightly down from CNY 137,342,297.94 in 2023[15]. - Financial expenses for the first three quarters of 2024 were CNY 35,155,618.23, compared to CNY 22,482,833.33 in 2023, marking an increase of approximately 56.4%[15]. - The company reported a significant increase in contract liabilities from CNY 8,720,945.16 in 2023 to CNY 113,035,257.28 in Q3 2024, reflecting a growth of over 1,200%[15].